Literature DB >> 21282595

Zoster sine herpete: virologic verification by detection of anti-VZV IgG antibody in CSF.

D T Blumenthal1, E Shacham-Shmueli, F Bokstein, D S Schmid, R J Cohrs, M A Nagel, R Mahalingam, D Gilden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21282595      PMCID： PMC3034410          DOI： 10.1212/WNL.0b013e31820a0d28

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  Zoster sine herpete.

Authors:  G W LEWIS
Journal:  Br Med J       Date:  1958-08-16

Review 2.  Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature.

Authors:  Aaron Haug; Ravi Mahalingam; Randall J Cohrs; D Scott Schmid; John R Corboy; Don Gilden
Journal:  J Neurol Sci       Date:  2010-02-19       Impact factor: 3.181

3.  Another case of virologically confirmed zoster sine herpete, with electrophysiologic correlation.

Authors:  C Amlie-Lefond; G A Mackin; M Ferguson; R R Wright; R Mahalingam; D H Gilden
Journal:  J Neurovirol       Date:  1996-04       Impact factor: 2.643

4.  Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

Authors:  A de Gramont; A Figer; M Seymour; M Homerin; A Hmissi; J Cassidy; C Boni; H Cortes-Funes; A Cervantes; G Freyer; D Papamichael; N Le Bail; C Louvet; D Hendler; F de Braud; C Wilson; F Morvan; A Bonetti
Journal:  J Clin Oncol       Date:  2000-08       Impact factor: 44.544

Review 5.  Zoster sine herpete, a clinical variant.

Authors:  D H Gilden; R R Wright; S A Schneck; J M Gwaltney; R Mahalingam
Journal:  Ann Neurol       Date:  1994-05       Impact factor: 10.422

6.  The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy.

Authors:  M A Nagel; B Forghani; R Mahalingam; M C Wellish; R J Cohrs; A N Russman; I Katzan; R Lin; C J Gardner; D H Gilden
Journal:  Neurology       Date:  2007-02-07       Impact factor: 9.910

7.  Recurrent varicella zoster virus myelopathy.

Authors:  Don Gilden; Maria A Nagel; Richard M Ransohoff; Randall J Cohrs; Ravi Mahalingam; Jody L Tanabe
Journal:  J Neurol Sci       Date:  2008-10-21       Impact factor: 3.181
  7 in total
  17 in total

1.  Reactivation of type 1 herpes simplex virus and varicella zoster virus in an immunosuppressed patient with acute peripheral facial weakness.

Authors:  Jean Tsai; Randall J Cohrs; Maria A Nagel; Ravi Mahalingam; D Scott Schmid; Alexander Choe; Don Gilden
Journal:  J Neurol Sci       Date:  2011-09-15       Impact factor: 3.181

2.  Robust gene expression changes in the ganglia following subclinical reactivation in rhesus macaques infected with simian varicella virus.

Authors:  Nicole Arnold; Christine Meyer; Flora Engelmann; Ilhem Messaoudi
Journal:  J Neurovirol       Date:  2017-03-20       Impact factor: 2.643

Review 3.  Review: The neurobiology of varicella zoster virus infection.

Authors:  D Gilden; R Mahalingam; M A Nagel; S Pugazhenthi; R J Cohrs
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

4.  Subclinical reactivation of varicella zoster virus in all stages of HIV infection.

Authors:  Marius Birlea; Gabriele Arendt; Eser Orhan; D Scott Schmid; William J Bellini; Christian Schmidt; Don Gilden; Randall J Cohrs
Journal:  J Neurol Sci       Date:  2011-03-17       Impact factor: 3.181

Review 5.  Neurological complications of varicella zoster virus reactivation.

Authors:  Maria A Nagel; Don Gilden
Journal:  Curr Opin Neurol       Date:  2014-06       Impact factor: 5.710

6.  Translational medicine and varicella zoster virus: need for disease modeling.

Authors:  Aamir Shahzad; Don Gilden; Randall J Cohrs
Journal:  New Horiz Transl Med       Date:  2015-03-01

Review 7.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 8.  Varicella zoster vaccines and their implications for development of HSV vaccines.

Authors:  Anne A Gershon
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

Review 9.  Varicella-zoster.

Authors:  Don Gilden; Maria A Nagel; Randall J Cohrs
Journal:  Handb Clin Neurol       Date:  2014

10.  Infections in the differential diagnosis of Bell's palsy: a plea for performing CSF analysis.

Authors:  Katrin Henkel; Peter Lange; Helmut Eiffert; Roland Nau; Annette Spreer
Journal:  Infection       Date:  2016-08-16       Impact factor: 7.455
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.